Novel therapy with LSD-1 inhibitor for cats with oral squamous cell carcinoma
condition(s)
oral squamous cell carcinoma
eligibility information
Enrollment Deadline
Enrollment ends September 3, 2024
Enrollment ends September 3, 2024